A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis

ConclusionsThe medical device has demonstrated good efficacy in the reduction of visible AKs, encouraging its use.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research